PI Industries exercises conversion of OFCD into equity in subsidiary PI Health Sciences

M&A / JV 23 Jun 2026 · Completed· ✓ Verified

PI Industries Limited, a publicly listed pharmaceutical company, exercised a contractual conversion right embedded in Optionally Fully Convertible Debentures that had been issued by its 100%-owned subsidiary, PI Health Sciences Limited. The conversion of debt into equity alters the subsidiary's ownership structure and capitalisation. No acquisition of external assets or third-party stake is involved; this is an intra-group reorganisation. The specific number of shares into which the debentures were converted, and the date of conversion, are not disclosed in the NSE notification.

Why it mattersConversion of OFCDs by a parent into equity of a wholly owned subsidiary raises questions on whether the conversion triggers fresh valuation, arm's-length pricing scrutiny under related-party transaction rules, and whether the subsidiary's updated cap table requires shareholder approval or stamp duty re-assessment under the Indian Stamp Act.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals